These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 2846155

  • 1. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M.
    Cancer Res; 1988 Dec 01; 48(23):6625-33. PubMed ID: 2846155
    [Abstract] [Full Text] [Related]

  • 2. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
    Zwelling LA, Hinds M, Chan D, Altschuler E, Mayes J, Zipf TF.
    Cancer Res; 1990 Nov 15; 50(22):7116-22. PubMed ID: 2171756
    [Abstract] [Full Text] [Related]

  • 3. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
    Constantinou A, Henning-Chubb C, Huberman E.
    Cancer Res; 1989 Mar 01; 49(5):1110-7. PubMed ID: 2537141
    [Abstract] [Full Text] [Related]

  • 4. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M, Chan D, Freireich EJ, Marton LJ, Zwelling LA.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [Abstract] [Full Text] [Related]

  • 5. Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.
    Kim HK, Zwelling LA, Sacks PG, Hong WK, Chan D, Silberman L, Glisson BS.
    Cancer Res; 1989 Mar 01; 49(5):1197-201. PubMed ID: 2537145
    [Abstract] [Full Text] [Related]

  • 6. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC, Ashorn CL, Chan D, Zwelling LA.
    Cancer Res; 1989 Apr 15; 49(8):2052-8. PubMed ID: 2539251
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide.
    DeVore RF, Corbett AH, Osheroff N.
    Cancer Res; 1992 Apr 15; 52(8):2156-61. PubMed ID: 1313738
    [Abstract] [Full Text] [Related]

  • 8. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
    Zwelling LA, Estey E, Silberman L, Doyle S, Hittelman W.
    Cancer Res; 1987 Jan 01; 47(1):251-7. PubMed ID: 3024817
    [Abstract] [Full Text] [Related]

  • 9. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
    Chresta CM, Hall BF, Francis GE.
    Leukemia; 1995 Aug 15; 9(8):1373-81. PubMed ID: 7643627
    [Abstract] [Full Text] [Related]

  • 11. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
    Tonetti DA, Horio M, Collart FR, Huberman E.
    Cell Growth Differ; 1992 Oct 15; 3(10):739-45. PubMed ID: 1445803
    [Abstract] [Full Text] [Related]

  • 12. The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA, Altschuler E, Mayes J, Hinds M, Chan D.
    Cancer Chemother Pharmacol; 1991 Oct 15; 29(1):48-52. PubMed ID: 1660353
    [Abstract] [Full Text] [Related]

  • 13. Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
    Ritke MK, Murray NR, Allan WP, Fields AP, Yalowich JC.
    Mol Pharmacol; 1995 Nov 15; 48(5):798-805. PubMed ID: 7476909
    [Abstract] [Full Text] [Related]

  • 14. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
    Ganapathi R, Constantinou A, Kamath N, Dubyak G, Grabowski D, Krivacic K.
    Mol Pharmacol; 1996 Aug 15; 50(2):243-8. PubMed ID: 8700130
    [Abstract] [Full Text] [Related]

  • 15. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
    Epstein RJ, Smith PJ.
    Cancer Res; 1988 Jan 15; 48(2):297-303. PubMed ID: 2825970
    [Abstract] [Full Text] [Related]

  • 16. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.
    Jensen PB, Sørensen BS, Demant EJ, Sehested M, Jensen PS, Vindeløv L, Hansen HH.
    Cancer Res; 1990 Jun 01; 50(11):3311-6. PubMed ID: 2159380
    [Abstract] [Full Text] [Related]

  • 17. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
    Báez A, Riou JF, Le Pecq JB, Riou G.
    Mol Pharmacol; 1990 Mar 01; 37(3):377-82. PubMed ID: 2156151
    [Abstract] [Full Text] [Related]

  • 18. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
    Markovits J, Pommier Y, Kerrigan D, Covey JM, Tilchen EJ, Kohn KW.
    Cancer Res; 1987 Apr 15; 47(8):2050-5. PubMed ID: 3030540
    [Abstract] [Full Text] [Related]

  • 19. Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II.
    Potmesil M, Hsiang YH, Liu LF, Bank B, Grossberg H, Kirschenbaum S, Forlenza TJ, Penziner A, Kanganis D.
    Cancer Res; 1988 Jun 15; 48(12):3537-43. PubMed ID: 2836060
    [Abstract] [Full Text] [Related]

  • 20. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y, Kerrigan D, Schwartz RE, Swack JA, McCurdy A.
    Cancer Res; 1986 Jun 15; 46(6):3075-81. PubMed ID: 3009009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.